Page 97 - 2020年20期
P. 97

pathology[J]. J Psychiatry Neurosci,2013,38(1):6-23.  rotenoid,attenuates β-amyloid oligomer-induced neurotox-
        [ 3 ]  WU XG,WANG SS,MIAO H,et al. Scutellaria barbata fla-  icity possibly via regulating the PI3K/Akt and the ERK
             vonoids alleviate memory deficits and neuronal injuries in-  pathways in SH-SY5Y cells[J]. Oxid Med Cell Longev,
             duced by composited A β in rats[J]. Behav Brain Funct,  2017. DOI:10.1155/2017/6792543.
             2016. DOI:10.1186/s12993-016-0118-8.          [16]  MANTZAVINOSA V,ALEXIOU A. Biomarkers for Alz-
        [ 4 ]  LAMBERT MP,VELASCO PT,CHANG L,et al. Mono-       heimer’s disease diagnosis[J]. Curr Alzheimer Rse,2017,
             clonal antibodies that target pathological assemblies of  14(11):1149-1154.
             Aβ[J]. J Neur,2007,100(1):23-35.              [17]  HARDY J,SELKOE DJ. The Amyloid hypothesis of Alz-
        [ 5 ]  SHEN WX,CHEN JH,LU JH,et al. TGF-β 1 protection  heimer’s disease:progress and problems on the road to
             against Aβ 1-42-induced neuroinflammation and neurodegen-  therapeutics[J]. Science,2002,297(5580):353-356.
             eration in rats[J]. Int J Mol Sci,2014,15(12):22092-  [18]  KARAKIDA F,IKEYA Y,TSUNAKAWA M,et al. Cere-
             22108.                                             bral protective and cognition-improving effects of sinapic
        [ 6 ]  PENG MY,LING XM,SONG RX,et al. Upregulation of   acid in rodents[J]. Biol Pharm Bull,2007,30(3):514-
             GLT-1 via PI3K/Akt pathway contributes to neuroprotec-  519 .
             tion induced by dexmedetomidine[J]. Front Neurol,2019.  [19]  CHEN CY. Sinapic acid and its derivatives as medicine in
             DOI:10.3389/fneur.2019.01041.                      oxidative stress-induced diseases and aging[J]. Oxid Med
        [ 7 ]  GHARBI SI,ZVELEBIL MJ,SHUTTLEWORTH SJ,et al.     Cell Longev,2016. DOI:10.1155/2016/3571614.
             Exploring the specificity of the PI3K family inhibitor  [20]  RYU JH,KIM SY,JANG CG,et al. Anxiolytic and memo-
             LY294002[J]. Biochem J,2007,404(1):15-21.          ry-improving composition causing no side effects compri-
        [ 8 ]  JIANG W,LUO T,LI S,et al. Quercetin protects against  sing phenylpropanoid compounds including cinnamic
             okadaic acid-induced injury via MAPK and PI3K/Akt/  acid,p-courmaric acid,caffeic acid,ferulic acid and
             GSK3β signaling pathways in HT22 hippocampal neurons  sinapic acid:Korea,KR740566-B1[P]. 2008-09-29.
             [J].  PLoS  One, 2016.  DOI: 10.1371/journal.pone.  [21]  HOFMANN BT,JÜCKER M. Activation of PI3K/Akt sig-
             0152371.                                           naling by N-terminal SH2 domain mutants of the p85 α
        [ 9 ]  LAFERLA FM,TINKLE BT,BIEBERICH CJ,et al. The     regulatory subunit of PI3K is enhanced by deletion of its
             Alzheimer’s A beta peptide induces neurodegeneration  C-terminal SH2 domain[J]. Cell Signal,2012,24(10):
             and apoptotic cell death in transgenic mice[J]. Nat Genet,  1950-1954.
             1995,9(1):21-30.                              [22]  TATO I,BARTRONS R,VENTURA F,et al. Amino acids
        [10]  XIAN YF,LIN ZX,MAO QQ,et al. Isorhynchophylline   activate mammalian target of rapamycin complex 2
             protects PC12 cells against beta-amyloid-induced apopto-  (mTORC2)via PI3K/Akt signaling[J]. J Biol Chem,
             sis via PI3K/Akt signaling pathway[J]. Evid Base Comple-  2011,286(8):6128-6142.
             ment Alternat Med,2013. DOI:10.1155/2013/163057.  [23]  GRIFFIN RJ,MOLONEY A,KELLIHER M,et al. Activa-
        [11]  KLYUBIN I,CULLEN WK,HU NW,et.al. Alzheimer’s      tion of Akt /PKB,increased phosphorylation of Akt sub-
             disease Aβ assemblies mediating rapid disruption of syn-  strates and loss and altered distribution of Akt and PTEN
             aptic plasticity and memory[J]. Mol Brain,2012. DOI:  are features of Alzheimer’s disease pathology[J]. J Neuro-
             10.1186/1756-6606-5-25.                            chem,2005,93(1):105-117.
        [12]  LEE HE,KIM DH,PARK SJ,et al. Neuroprotective effect  [24]  YAO YJ,WANG YM,KONG L,et al. Osthole decreases
             of sinapic acid in a mouse model of amyloid β 1-42 protein-  tau protein phosphorylation via PI3K/AKT/GSK-3β sig-
             induced Alzheimer’s disease[J]. Pharmacol Biochem Be-  naling pathway in Alzheimer’s disease[J]. Life Sci,2019,
             hav,2012,103(2):260-266.                           15(1):16-24.
        [13]  KIM DH,YOON BH,JUNG WY,et al. Sinapic acid atten-  [25]  NISBET RM,POLANCO JC,ITTNER LM,et al. Tau ag-
             uates kainic acid-induced hippocampal neuronal damage  gregation and its interplay with amyloid-β[J]. Acta Neuro-
             in mice[J]. Neuropharmacology,2010,59(1/2):20-30.  pathol,2014,129(2):207-220.
        [14]  SHAHMOHAMADY P,EIDI A,MORTAZAVI P,et al.     [26]  BAE IS,KIM SH. Sinapic acid promotes browning of 3T3-
             Effect of sinapic acid on memory deficits and neuronal de-  L1 adipocytes via p38 MAPK/CREB pathway[J]. Biomed
             generation induced by intracerebroventricular administra-  Res Int,2020. DOI:10.1155/2020/5753623.
             tion of streptozotocin in rats[J]. Pol J Pathol,2018,69    (收稿日期:2020-04-04   修回日期:2020-08-04)
            (3):266-277.                                                                        (编辑:罗 瑞)
        [15]  LIN JJ,YU J,ZHAO JY,et al. Fucoxanthin,a marine ca-






        中国药房    2020年第31卷第20期                                            China Pharmacy 2020 Vol. 31 No. 20  ·2523 ·
   92   93   94   95   96   97   98   99   100   101   102